KCNH1 and cancer: Here, we present a new series of potent nanomolar KV10.1 inhibitors obtained by structural optimisation of previously published compounds 1 and 2 We also demonstrated the potential of this new structural class of Kv10.1 inhibitors for antiproliferative activity in MCF-7 cancer cell models.